Using fluorescent dye to see kidney cancer during removal surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a special dye, taken as a drink before surgery, makes kidney cancer cells glow under a fluorescent light. This may help surgeons remove the tumor more completely while saving healthy kidney tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled to have surgery to remove a kidney tumor (partial nephrectomy).
- You can give your informed consent to participate.
- You do not have a condition called porphyria or an allergy to porphyrins.
- You are not pregnant or breastfeeding.
- Your liver function tests are within normal limits (not more than twice the upper limit) in the last 30 days.
- You have not taken part in another research study in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a drug called 5-ALA before a scope procedure helps doctors spot cancer cells in the upper urinary tract more clearly. If you are having a scope to check for or treat a tumor in this area, this experimental imaging method might help guide treatment.
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
This trial tests a drug called 5-ALA that makes brain tumor cells glow under a special light during surgery. This helps surgeons see and remove more of the tumor safely, potentially improving outcomes for children with high-grade brain tumors.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This trial tests a special dye that helps surgeons see tumors more clearly during surgery, followed by a light therapy to destroy any remaining cancer cells. It is for people with advanced or returning colorectal cancer who are already scheduled for surgery.
This study tests a special dye, called pafolacianine, that is injected before surgery to help surgeons see hidden cancer spots in the belly during the operation. The goal is to see if using this dye improves how completely the cancer is removed in people with gastrointestinal cancer that has spread to the belly lining.
Hear when a new Kidney Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.